tiprankstipranks
Pharmaxis Ltd (AU:SNT)
ASX:SNT
Holding AU:SNT?
Track your performance easily

Pharmaxis Ltd (SNT) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Pharmaxis Ltd’s (SNT) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Pharmaxis Ltd is a Sell.
Pharmaxis Ltd’s (SNT) 20-Day exponential moving average is 0.05, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) 50-Day exponential moving average is 0.04, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.

Pharmaxis Ltd (SNT) Pivot Points

Dec 23, 2024, 12:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.05
0.06
0.06
0.06
0.06
0.07
Fibonacci
0.05
0.05
0.05
0.06
0.06
0.06
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaxis Ltd (SNT) Moving Averages

Dec 23, 2024, 12:39 AM
Period
Simple
Exponential
MA5
0.05Buy
0.05Buy
MA10
0.05Buy
0.05Buy
MA20
0.04Buy
0.05Buy
MA50
0.04Buy
0.04Buy
MA100
0.04Buy
0.04Buy
MA200
0.03Buy
0.03Buy
Pharmaxis Ltd’s (SNT) 10-Day exponential moving average is 0.05, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) 100-Day exponential moving average is 0.04, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 50-day simple moving average is 0.04, creating a Buy signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 100-day simple moving average is 0.04, creating a Buy signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 200-day simple moving average is 0.03, creating a Buy signal.

Pharmaxis Ltd (SNT) Technical Indicators

Dec 23, 2024, 12:39 AM
Name
Value
Implied Action
RSI (14)
66.72
Neutral
STOCH (9,6)
97.16
Sell
STOCHRSI (14)
97.78
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
16.04
Buy
Williams %R
-14.29
Sell
CCI (14)
257.76
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
64.84
Neutral
ROC
50.00
Buy
Pharmaxis Ltd’s (SNT) Relative Strength Index (RSI) is 66.72, creating a Neutral signal.
Pharmaxis Ltd’s (SNT) Trend Strength Indicator (ADX) is 16.04, creating a Buy signal.
Pharmaxis Ltd’s (SNT) Commodity Channel Index (CCI) is 257.76, creating a Sell signal.
Pharmaxis Ltd’s (SNT) Price Rate of Change (ROC) is 50.00, creating a Buy signal.

FAQ

Is SNT a Buy, Hold, or Sell?
Based on SNT’s technical indicators, SNT is a Buy.
    What is SNT’s RSI (14)?
    SNT’s RSI (14) is 66.72, which suggests SNT is a Neutral.
      What is SNT’s MACD?
      SNT’s MACD is <0.01, which suggests SNT is a Sell.
        What is SNT’s 5-day moving average?
        SNT’s 5-day moving average is 0.05, which suggests SNT is a Buy.
          What is SNT’s 20-day moving average?
          SNT 20-day moving average is 0.04, which suggests SNT is a Buy.
            What is SNT’s 50-day moving average?
            SNT’s 50-day moving average is 0.04, which suggests SNT is a Buy.
              What is SNT’s 200-day moving average?
              SNT’s 200-day moving average is 0.03, which suggests SNT is a Buy.
                What is SNT’s Williams % R (14)?
                SNT’s Williams % R (14) is -14.29, which suggests SNT is a Sell.
                  What is SNT’s CCI (14)?
                  SNT’s CCI (14) is 257.76, which suggests SNT is a Sell.
                    What is the share price of Pharmaxis Ltd?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis